Adolescents' symptoms of anxiety and depression before and during the Covid-19 outbreak - a prospective population-based study of teenagers in Norway - Hafstad GS, S ætren SS, Wentzel-Larsen T, Augusti EM.
BACKGROUND: Lockdown policies related to the Sars-Cov-2 pandemic has potential negative consequences for mental health in youths. METHODS: Anxiety and depressive symptoms were assessed in 3 572 adolescents, age 13 to 16 using the Hopkins Symptom Ch... (Source: SafetyLit)
Source: SafetyLit - September 27, 2021 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

The risk of COVID-19 in survivors of domestic violence and abuse - Chandan JS, Subramanian A, Chandan JK, Gokhale KM, Vitoc A, Taylor J, Bradbury-Jones C, Bandyopadhyay S, Nirantharakumar K.
A 'shadow pandemic' of domestic violence and abuse (DVA) has emerged secondary to strict public health measures containing the spread of SARS-CoV-2. Many countries have implemented policies to allow the free movement of DVA survivors in attempts to minimis... (Source: SafetyLit)
Source: SafetyLit - September 27, 2021 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Africa: Want to Develop Vaccines in Africa?
[The Conversation Africa] In little more than a year from the onset of COVID-19, scientists successfully developed vaccines against the SARS-CoV-2 virus for world-wide use. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - September 26, 2021 Category: African Health Source Type: news

Africa: What the Objections to Covid-19 Control Measures Tell Us About Personal Freedom
[The Conversation Africa] As the protracted global battle with SARS-CoV-2 continues to rage, objections to the measures being taken to combat the virus are increasing. Protests have been reported in countries such as the US, the UK, Australia, Thailand, South Africa, France, Italy, and Greece. In some instances, the protests have become violent resulting in injuries and arrests. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - September 25, 2021 Category: African Health Source Type: news

Guillain - Barr é Syndrome May Be Triggered by SARS - CoV - 2 Infection
During study period, 22 percent with GBS had confirmed or probable SARS - CoV - 2 infection; patients had uniform neurologic features (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - September 25, 2021 Category: Respiratory Medicine Tags: Infections, Internal Medicine, Critical Care, Emergency Medicine, Neurology, Pulmonology, Journal, Source Type: news

EARLY RELEASE: Pediatric COVID-19 Cases in Counties With and Without School Mask Requirements - United States, July 1-September 4, 2021
This report describes pediatric COVID-19 cases in counties with and without school mask requirements. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - September 24, 2021 Category: American Health Tags: Coronavirus [CoV] MMWR Morbidity & Mortality Weekly Report SARS (Severe acute respiratory syndrome) School Wellness Pediatric Patients COVID-19 Schools Facemasks Source Type: news

EARLY RELEASE: Association Between K-12 School Mask Policies and School-Associated COVID-19 Outbreaks - Maricopa and Pima Counties, Arizona, July-August 2021
This report describes Arizona school associated COVID-19 outbreaks higher in schools without mask requirements than in schools with mask requirements. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - September 24, 2021 Category: American Health Tags: Coronavirus [CoV] MMWR Morbidity & Mortality Weekly Report Outbreaks Personal Protective Equipment (PPE) SARS (Severe acute respiratory syndrome) School Wellness COVID-19 Schools K-12 Schools Prevention Infection Control Facema Source Type: news

Four new options to simplify your SARS-CoV-2 submissions
We have recently added several exciting improvements to the SARS-CoV-2 GenBank submission process based on community feedback. To save you time, NCBI completes feature annotation for you, which means SARS-CoV-2 GenBank submission only requires a FASTA file and source metadata. Here are other new features to ease and simplify your submission workflow. Automatically remove failed … Continue reading Four new options to simplify your SARS-CoV-2 submissions → (Source: NCBI Insights)
Source: NCBI Insights - September 24, 2021 Category: Databases & Libraries Authors: NCBI Staff Tags: What's New GenBank SARS-CoV-2 Submissions Source Type: news

Pfizer and BioNTech receive first U.S. FDA Emergency Use Authorization of a COVID-19 vaccine booster
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced that the U.S. Food and Drug Administration (FDA) has authorized for emergency use a booster dose of the Pfizer-BioNTech COVID-19 Vaccine for individuals 65 years of age and older, individuals 18 through 64 years of age at high risk of severe COVID-19, and individuals 18 through 64 years of age whose frequent institutional or occupational exposure to SARS-CoV-2 puts them at high risk of serious complications of COVID-19 including severe COVID-19. (Source: World Pharma News)
Source: World Pharma News - September 24, 2021 Category: Pharmaceuticals Tags: Featured Pfizer Business and Industry Source Type: news

CDC Panel Outlines Who Should Get Pfizer-BioNTech COVID-19 Booster Shots, And Who Should Wait
In a four-part vote, a Centers for Disease Control (CDC) committee today recommended booster shots of Pfizer-BioNTech’s COVID-19 vaccine for people 65 years or older, as well as anyone over 50 with certain underlying medical conditions. The committee also recommended allowing people 18- to 49-years-old with underlying medical conditions to receive a booster if they desired, based on individualized decisions about the benefits and risks to them. But in one of its four votes, the committee decided against recommending booster shots for adults working in high-risk settings such as health care and school systems. That vo...
Source: TIME: Health - September 24, 2021 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news

Use of Pfizer-BioNTech COVID-19 Vaccine in Persons Aged ≥16 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, September 2021
This report describes ACIP's standard recommendation for the Pfizer-BioNTech COVID-19  vaccine in persons 16 years or older. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - September 23, 2021 Category: American Health Tags: Adult Health Advisory Committee on Immunization Practices (ACIP) Coronavirus [CoV] Morbidity & Mortality Weekly Report Older Adults' Health SARS (Severe acute respiratory syndrome) Teen health Vaccination Vaccines COVID-19 Source Type: news

Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions - United States, March-August 2021
This report describes COVID-19 vaccine effectiveness against hospitalizations for all three vaccines, with Moderna as the most effective against hospitalization. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - September 23, 2021 Category: American Health Tags: Adult Health Coronavirus [CoV] Hospitalization rates Hospitals MMWR Morbidity & Mortality Weekly Report SARS (Severe acute respiratory syndrome) Vaccination Vaccines COVID-19 Source Type: news

Decreased Incidence of Infections Caused by Pathogens Transmitted Commonly Through Food During the COVID-19 Pandemic - Foodborne Diseases Active Surveillance Network, 10 U.S. Sites, 2017-2020
This report describes decreases in transmission of foodborne diseases during the COVID-19 pandemic. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - September 23, 2021 Category: American Health Tags: Coronavirus [CoV] Food-Related Diseases Foodborne Disease FoodNet MMWR Morbidity & Mortality Weekly Report SARS (Severe acute respiratory syndrome) COVID-19 Source Type: news

Increasing Access to HIV Testing Through Direct-to-Consumer HIV Self-Test Distribution - United States, March 31, 2020-March 30, 2021
This report describes a partnership to provide free HIV self-test kits to men who have sex with men. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - September 23, 2021 Category: American Health Tags: Coronavirus [CoV] Gay Men's Health Healthcare access HIV/AIDS MMWR Morbidity & Mortality Weekly Report SARS (Severe acute respiratory syndrome) COVID-19 Testing Source Type: news

Outbreak of SARS-CoV-2 B.1.617.2 (Delta) Variant Infections Among Incarcerated Persons in a Federal Prison - Texas, July-August 2021
This report describes an outbreak with the Delta variant in a federal Texas prison among unvaccinated and vaccinated persons. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - September 23, 2021 Category: American Health Tags: Coronavirus [CoV] MMWR Morbidity & Mortality Weekly Report Outbreaks SARS (Severe acute respiratory syndrome) Vaccination Vaccines COVID-19 Source Type: news

SARS-CoV-2 Testing for Medically Underserved Populations SARS-CoV-2 Testing for Medically Underserved Populations
This report describes a SARS-CoV-2 testing program that could help reach medically underserved communities with high rates of infection.Emerging Infectious Diseases (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 23, 2021 Category: Consumer Health News Tags: Infectious Diseases Journal Article Source Type: news

No evidence of any new variant of SARS-CoV2 in country: INSACOG
Last week, the INSACOG said India has so far not seen Mu and C.1.2, the two new variants of SARS'CoV2, and the Delta variant and its sub-lineages continue to be the main variants in the country. (Source: The Economic Times)
Source: The Economic Times - September 23, 2021 Category: Consumer Health News Source Type: news

Long COVID Appears to'Impair' Survival in Cancer Patients Long COVID Appears to'Impair' Survival in Cancer Patients
Ongoing complications following SARS-CoV-2 infection are associated with increased risk for mortality and treatment cessation.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 22, 2021 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

How SARS-CoV-2 Evades And Suppresses The Immune System (Part 13)
Today we turn our attention to the last remaining piece of the puzzle that is suppression of Covid-19 innate immune signaling: the M protein. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 22, 2021 Category: Pharmaceuticals Authors: William A. Haseltine, Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma & Source Type: news

Daily testing for contacts of individuals with SARS-CoV-2 infection and attendance and SARS-CoV-2 transmission in English secondary schools and colleges: an open-label, cluster-randomised trial, The Lancet
Daily contact testing of school-based contacts was non-inferior to self-isolation for control of COVID-19 transmission, with similar rates of symptomatic infections among students and staff with both approaches. Infection rates in school-based contacts were low, with very few school contacts testing positive. Daily contact testing should be considered for implementation as a safe alternative to home isolation following school-based exposures. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - September 22, 2021 Category: Consumer Health News Source Type: news

Portable Air Cleaners for Reducing Exposure to SARS-CoV-2 Portable Air Cleaners for Reducing Exposure to SARS-CoV-2
This study demonstrated that the use of portable HEPA air cleaners and universal masking is effective at reducing exposure to indoor aerosols containing SARS-CoV-2.Morbidity & Mortality Weekly Report (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 22, 2021 Category: Consumer Health News Tags: Public Health & Prevention Journal Article Source Type: news

Domestic violence against Latin American women and female mental health during the new coronavirus (SARS-CoV-2) outbreak - Gon çalves Júnior J, Maia MAG, Moreira JLS, Dias HS, Félix EB, Machado SSF.
We aimed to discuss the impact of the coronavirus pandemic on the VAW scenario and how it affects women's mental health. The short communication from secondary data collected from the official websites of seven countries in Latin America was performed. The... (Source: SafetyLit)
Source: SafetyLit - September 22, 2021 Category: International Medicine & Public Health Tags: Risk Factor Prevalence, Injury Occurrence Source Type: news

Viruses May Jump From Bats to People More Often Than Realized Viruses May Jump From Bats to People More Often Than Realized
Scientists studying coronaviruses like SARS-CoV-2 are taking blood samples from people in regions where there are lots of bats to estimate how often people encounter the viruses they carry.WebMD Health News (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - September 21, 2021 Category: Infectious Diseases Tags: Infectious Diseases News Source Type: news

EARLY RELEASE: Use of Pfizer-BioNTech COVID-19 Vaccine in Persons Aged ≥16 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, September 2021
This report describes ACIP's standard recommendation for the Pfizer-BioNTech COVID-19  vaccine in persons 16 years or older. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - September 21, 2021 Category: American Health Tags: Adult Health Advisory Committee on Immunization Practices (ACIP) Coronavirus [CoV] Morbidity & Mortality Weekly Report Older Adults' Health SARS (Severe acute respiratory syndrome) Teen health Vaccination Vaccines COVID-19 Source Type: news

Assessment and procurement of coronavirus (COVID-19) tests, DHSC (updated 21st September 2021)
How the government assesses offers of COVID-19 tests from developers for procurement and use in the UK. 21 September 2021Added new test: SARS CoV-2 + Influenza A/B (Roche Cobas Liat) to the'Validated technology'table in'National technical validation process for manufacturers of SARS-CoV-2 (COVID-19) tests'. 8 September 2021Updated'COVID-19 test approval – step 2: process for desktop review'to explain the use of the full dynamic range data for the regulation assessment and add an email address to request TVG data. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - September 21, 2021 Category: Consumer Health News Source Type: news

Johnson & Johnson Announces Real-World Evidence and Phase 3 Data Confirming Strong and Long-Lasting Protection of Single-Shot COVID-19 Vaccine in the U.S.
This study compared approximately 390,000 people who received the Company’s single-shot COVID-19 vaccine versus approximately 1.52 million unvaccinated people matched on age, sex, time, three-digit zip code, and comorbidities and predictors for COVID-19 infection severity.This study is a longitudinal cohort design, using robust propensity matching methods to create a comparator cohort to assess real-world VE. All analyses were performed using the Aetion Evidence Platform, which is a scientifically validated software that is also used by regulators, payers, and health technology assessment bodies to assess the safety,...
Source: Johnson and Johnson - September 21, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

An analysis of spatial characteristics of change in the number of passengers at individual bus stops under CoViD-19 - Bhin M, Son S, Joh CH.
COVID-19 virus is a type of virus that can infect human and many kinds of animals. It is defined as a Respiratory Syndrome by SARS-CoV-2. COVID-19 halts human movements for economic and social activities over the world. The futurologists predict such pande... (Source: SafetyLit)
Source: SafetyLit - September 21, 2021 Category: International Medicine & Public Health Tags: Engineering, Physics, Structural Soundness and Failure Source Type: news

Pandemic Cycles Of Covid-19: SARS-CoV-2 Immune Suppression Helps Us Understand Repeated Cycles Of Viral Infection And Vaccine Breakthrough
The more we understand what SARS-CoV-2 must do to evade our natural immune defenses, the more opportunities we have to create new ways to prevent and treat disease. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 20, 2021 Category: Pharmaceuticals Authors: William A. Haseltine, Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma & Source Type: news

A New US/Japan Variant To Watch
A new variant has been detected in a Kentucky nursing home, infecting 45 residents and health care personnel. Many of these infections arose in fully vaccinated individuals. The variant, which originated in Japan, has over 10,000 entries in the GISAID SARS-CoV-2 database. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 20, 2021 Category: Pharmaceuticals Authors: William A. Haseltine, Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma & Source Type: news

Major advance in race for SARS-CoV-2 inhibitor drugs
A new advance towards the development of drugs specifically designed to inhibit a key SARS-CoV-2 enzyme is reported in the Royal Society of Chemistry's leading journal, Chemical Science. The international team, led by scientists from the Universities of Oxford and Bristol, has designed new peptide molecules and shown that they block (inhibit) the virus ’ s main protease [Mpro] - a prominent SARS-CoV-2 drug target. (Source: University of Bristol news)
Source: University of Bristol news - September 20, 2021 Category: Universities & Medical Training Tags: International, Research; Faculty of Science, Faculty of Science, School of Chemistry, Faculty of Life Sciences, Faculty of Life Sciences, School of Biochemistry; Press Release Source Type: news

Patients aren't being told what "variant" they're infected with; no diagnostic tests in the field are even capable of determining variants
(Natural News) Polymerase chain reaction (PCR) tests for the Wuhan coronavirus (COVID-19) are part of many countries’ response to the pandemic. However, these tests do not allow people to know what particular SARS-CoV-2 variant is behind their sickness. Many patients have thus claimed that laboratories refusing to disclose their complete COVID-19 test results violate their... (Source: NaturalNews.com)
Source: NaturalNews.com - September 20, 2021 Category: Consumer Health News Source Type: news

Closing COVID-19 mortality, vaccination, and evidence gaps for those with severe mental illness, Lancet Psychiatry
In The Lancet Psychiatry, Dana Tzur Bitan and colleagues present the results of the first longitudinal study assessing COVID-19 outcomes before and after vaccination in a cohort of over 25 000 people with schizophrenia and an equally large sample of matched controls in Israel. Particular strengths of this study are the impressive and well-characterised dataset, and the longitudinal design, allowing exploration of dynamic trends over the course of the first year of the COVID-19 pandemic. From a policy perspective, Israel, where all citizens aged 16 and older gained full access to SARS-CoV-2 vaccination as early as January, ...
Source: Current Awareness Service for Health (CASH) - September 20, 2021 Category: Consumer Health News Source Type: news

FDA Panel Recommends Against Following White House Plan for Booster Doses for All
A U.S. Food and Drug Administration (FDA) committee voted unanimously Friday to recommend booster doses of Pfizer-BioNTech’s COVID-19 vaccine for those over age 65 and those at higher risk of exposure to the virus, including healthcare, frontline and essential workers, under emergency use authorization, but stopped short of recommending boosters for the general population. (Boosters have already been authorized for those with compromised immune systems.) Pfizer-BioNTech had originally requested that the FDA consider full approval of a booster dose for all people who have been vaccinated with its shot. The 18 members ...
Source: TIME: Health - September 18, 2021 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news

Success of COVID-19 Vaccines in Nursing Homes: Will It Stick? Success of COVID-19 Vaccines in Nursing Homes: Will It Stick?
Several studies support the effectiveness of COVID-19 vaccines in reducing SARS-CoV-2 infection and its complications in nursing homes, but as this commentary underscores, we can't let down our guard.Journal of the American Geriatrics Society (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 17, 2021 Category: Consumer Health News Tags: Internal Medicine Journal Article Source Type: news

Department of Justice Recovers $1.8B from Medical Laboratory Owners and Others Accused of Alleged Healthcare Fraud During COVID-19 Pandemic
It did not take long for fraudsters to pursue hundreds of billions of federal dollars designated to support SARS-CoV-2 testing and it is rare when federal prosecutors bring cases only a few months after illegal lab testing schemes are identified As if the COVID-19 pandemic weren’t bad enough, unscrupulous clinical laboratory operators quickly sought to […] The post Department of Justice Recovers $1.8B from Medical Laboratory Owners and Others Accused of Alleged Healthcare Fraud During COVID-19 Pandemic appeared first on Dark Daily. (Source: Dark Daily)
Source: Dark Daily - September 17, 2021 Category: Laboratory Medicine Authors: Jillia Schlingman Tags: Coding, Billing, and Collections Compliance, Legal, and Malpractice Laboratory News Laboratory Pathology Laboratory Testing Managed Care Contracts & Payer Reimbursement anatomic pathology cardiac testing centers for medicare and medicaid s Source Type: news

Nephrotic Syndrome and Vasculitis After SARS-CoV-2 Vaccine Nephrotic Syndrome and Vasculitis After SARS-CoV-2 Vaccine
Are reported cases of nephrotic syndrome and vasculitis associated with the administration of the COVID-19 vaccine?Nephrology Dialysis Transplantation (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - September 17, 2021 Category: Intensive Care Tags: Nephrology Journal Article Source Type: news

STUDY: Delta variant could become completely immune to all existing vaccines
(Natural News) New research out of Japan suggests that the dreaded “Delta variant” may soon become completely “resistant” to Wuhan coronavirus (Covid-19) “vaccines.” Experts found that the SARS-CoV-2 Delta variant is already “poised to acquire complete resistance” to all existing jabs for the Chinese Virus. Truth be told, the jabs are responsible for spreading the... (Source: NaturalNews.com)
Source: NaturalNews.com - September 16, 2021 Category: Consumer Health News Source Type: news

Disaggregating Data to Measure Racial Disparities in COVID-19 Outcomes and Guide Community Response - Hawaii, March 1, 2020-February 28, 2021
This report describes racial disparities in COVID-19 infections among person living in Hawaii. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - September 16, 2021 Category: American Health Tags: Coronavirus [CoV] Data & Statistics MMWR Morbidity Mortality Weekly Report SARS (Severe acute respiratory syndrome) COVID-19 Source Type: news

Effectiveness of COVID-19 mRNA Vaccines Against COVID-19-Associated Hospitalization - Five Veterans Affairs Medical Centers, United States, February 1-August 6, 2021
COVID-19 mRNA vaccine effectiveness among U.S. veterans remains high, even during Delta variant spread. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - September 16, 2021 Category: American Health Tags: Coronavirus [CoV] Hospitalization rates Morbidity & Mortality Weekly Report SARS (Severe acute respiratory syndrome) Vaccination Vaccine-Preventable Diseases and Specific Vaccines Veterans Health COVID-19 Source Type: news

Interim Estimates of COVID-19 Vaccine Effectiveness Against COVID-19-Associated Emergency Department or Urgent Care Clinic Encounters and Hospitalizations Among Adults During SARS-CoV-2 B.1.617.2 (Delta) Variant Predominance - Nine States, June-August 2021
COVID-19 vaccine effectiveness against emergency department/urgent care visits and hospitalizations. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - September 16, 2021 Category: American Health Tags: Coronavirus [CoV] Emergency Department Visits Hospitalization rates Morbidity & Mortality Weekly Report SARS (Severe acute respiratory syndrome) Vaccination Vaccine Safety Vaccine-Preventable Diseases and Specific Vaccines COVID-19 Source Type: news

Monitoring Incidence of COVID-19 Cases, Hospitalizations, and Deaths, by Vaccination Status - 13 U.S. Jurisdictions, April 4-July 17, 2021
After the COVID-19 B.1.617.2 (Delta) variant reached predominance, fully vaccinated people had less risk of infection, hospitalization, and death. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - September 16, 2021 Category: American Health Tags: Coronavirus [CoV] Hospitalization rates Infection Morbidity & Mortality Weekly Report Prevention SARS (Severe acute respiratory syndrome) Vaccination Vaccines Death Rates COVID-19 Source Type: news

Post-Acute Sequelae of SARS-CoV-2 Infection Among Adults Aged ≥18 Years - Long Beach, California, April 1-December 10, 2020
This report describes identification of post-acute sequelae in recovered COVID-19 patients in Long Beach, California. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - September 16, 2021 Category: American Health Tags: Coronavirus [CoV] MMWR Morbidity & Mortality Weekly Report SARS (Severe acute respiratory syndrome) Long-term Care COVID-19 Source Type: news

New COVID-19 Cases and Hospitalizations Among Adults, by Vaccination Status - New York, May 3-July 25, 2021
COVID-19 vaccine effectiveness against hospitalizations was stable, but it declined against new infections among adults in New York during May-July 2021. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - September 16, 2021 Category: American Health Tags: Coronavirus [CoV] Hospitalization rates Hospitals MMWR Morbidity & Mortality Weekly Report SARS (Severe acute respiratory syndrome) Vaccination Vaccines COVID-19 Source Type: news

Correction and Republication: New COVID-19 Cases and Hospitalizations Among Adults, by Vaccination Status - New York, May 3-July 25, 2021
This report describes a correction to a previously published report in MMWR. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - September 16, 2021 Category: American Health Tags: Coronavirus [CoV] Hospitalization rates Hospitals MMWR Morbidity & Mortality Weekly Report SARS (Severe acute respiratory syndrome) Vaccination Vaccines COVID-19 Source Type: news

Moderna ’s Case for a COVID-19 Booster Shot: Its Vaccine Protection Wanes by 36% After 12 Months, According to a New Study
Studies from COVID-19 vaccine makers and public health officials have been suggesting for a while that protection provided by the vaccines wanes over time. In a new study published on Sept. 15 to a preprint server—the study is not yet peer-reviewed—researchers at Moderna, which makes one of the two mRNA COVID-19 vaccines (the other is from Pfizer-BioNTech), report that people vaccinated within the last eight months had 36% fewer breakthrough infections than those who were vaccinated a year ago. That suggests vaccine-induced immunity is likely highest shortly after people get their recommended two doses of the v...
Source: TIME: Health - September 16, 2021 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news

Moderna ’s Case for a COVID-19 Booster Shot: Its Vaccine Protection Wanes by 36% After 12 Months, According to a New Study
Studies from COVID-19 vaccine makers and public health officials have been suggesting for a while that protection provided by the vaccines wanes over time. In a new study published on Sept. 15 to a preprint server—the study is not yet peer-reviewed—researchers at Moderna, which makes one of the two mRNA COVID-19 vaccines (the other is from Pfizer-BioNTech), report that people vaccinated within the last eight months had 36% fewer breakthrough infections than those who were vaccinated a year ago. That suggests vaccine-induced immunity is likely highest shortly after people get their recommended two doses of the v...
Source: TIME: Science - September 16, 2021 Category: Science Authors: Alice Park Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news

A Second East African Variant: A.23.1
A new and unusual variant of SARS-CoV-2 has been found in Africa. First detected in Uganda as early as October 2020, the A.23.1 variant is now found in at least 26 other countries. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 16, 2021 Category: Pharmaceuticals Authors: William A. Haseltine, Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma & Source Type: news

Impact of a national lockdown on cycling injuries - Foley J, Robinson M, Ryan J, Cronin J.
Introduction The Sars-CoV-2 pandemic led to a national lockdown in Ireland from March 12th to June 7th, 2020. The present study aimed to assess the change in the pattern of cycling attendances to an Irish ED during a pandemic. METHODS This is a ret... (Source: SafetyLit)
Source: SafetyLit - September 16, 2021 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

COVID-19 nasal vaccine candidate effective at preventing disease transmission
Breathe in, breathe out. That’s how easy it is for SARS-CoV-2, the virus that causes COVID-19, to enter your nose. And though remarkable progress has been made in developing intramuscular vaccines against SARS-CoV- 2, such as the readily available Pfizer, Moderna and Johnson & Johnson vaccines, nothing yet - like a nasal vaccine - has been approved to provide mucosal immunity in the nose, the first barrier against the virus before it travels down to the lungs. (Source: World Pharma News)
Source: World Pharma News - September 16, 2021 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Strength in numbers: Federated learning boosts AI for COVID-19
An algorithm trained using federated learning turned in highly accurate performanc...Read more on AuntMinnie.comRelated Reading: Chest CT score predicts ventilation failure in COVID-19 patients Lung abnormalities persist in 91% of COVID-19 patients Chest x-ray inflammation severity score hones COVID-19 detection AI model identifies SARS-CoV-2 from blood tests, chest x-rays Federated learning may boost AI generalizability (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 16, 2021 Category: Radiology Source Type: news